-
- Posted Friday November 25, 2005
TGen Partners with Morehouse School of Medicine to Perform Translational Research
Collaboration leverages strengths of both institutions
Phoenix, AZ, November 22, 2005-The Translational Genomics Research
Institute (TGen) has entered into a research collaboration with the
Morehouse School of Medicine (MSM), located in Atlanta, GA, to
carry out joint projects in Neuroscience, Cancer, and
Cardiovascular Disease. The partnership leverages the strengths of
both institutions to accomplish their translational research
missions. Additionally, TGen and MSM are setting up a joint seed
fund that allows faculty from each institution to collaborate on
shared endeavors.
Dr. David Satcher, 16th Surgeon General of the United States and
current Interim President and Director of the Center of Excellence
for Health Disparities at the Morehouse School of Medicine,
traveled to TGen to sign the agreement.
Dr. Jeffrey Trent and Dr. David Satcher sign a collaborative
research agreement to carry out joint projects in Neuroscience,
Cancer, and Cardiovascular Disease.
"We are very enthusiastic about the evolution of our relationship
with TGen," said Dr. Satcher at the signing ceremony. "Like TGen,
we are also a young institution-celebrating our 30th anniversary
this year-and I look forward to developing our relationship with
TGen into a real partnership."
The TGen-MSM partnership furthers the school's potential to emerge
as a preeminent minority organization in translational genomics
research and allows TGen to make a positive impact in creating
earlier diagnostic tools and treatments for disease.
TGen shares the common goal with the MSM to eliminate health
disparities. The joint seed fund will further open communications
between investigators at TGen and MSM, allowing them to work
together on research projects and shared intellectual
interests.
"This is a special opportunity for TGen and the Morehouse School
of Medicine to work together toward translating genomic research
into earlier tests and therapies for patients who need it most,"
said Dr. Jeffrey Trent, president and scientific director of TGen.
"The partnership with the Morehouse School of Medicine increases
TGen's impact through partnering with a college known for
addressing health disparities in a significant way."
After the signing ceremony, Dr. Satcher gave a lecture at Phoenix
College that focused on what it takes to eliminate disparities in
health. Dr. Satcher highlighted MSM's three-dimensional approach to
eliminating health disparities, which include monitoring diseases
such as diabetes, HIV/AIDS, cardiovascular disease/stroke and
cancer, having a balanced research agenda, and conducting
translational research.
"We need to take scientific results from the bench to the patient
bedside and then into the community as a way of translating
research," said Dr. Satcher.
# # #
Media Contact:
Amy Erickson-TGen (602) 343-8522
About TGen
The mission of the Translational Genomics Research Institute
(TGen) is to make and translate genomic discoveries into advances
in human health. Translational genomics research is a relatively
new field employing innovative advances arising from the Human
Genome Project and applying them to the development of diagnostics,
prognostics and therapies for cancer, neurological disorders,
diabetes and other complex diseases. TGen is focused on
personalized medicine and plans to accomplish its goals through
robust and disease-focused research.
About the Morehouse School of Medicine
The Morehouse School of Medicine is a historically black
institution established to recruit and train minority and other
students as physicians, biomedical scientists, and public
healthcare professionals committed to the primary healthcare needs
of the underserved.
